Good afternoon Ladies and Gentlemen,
The 2016 financial year was a challenging year as your company commenced a significant review and restructure of operations. Some of these initiatives included the transition of manufacturing to the USA, product review and rationalisation and full FDA regulatory compliance and research and development initiatives. The Directors are confident that these initiatives will be beneficial in the medium to long term for both the sustainable future and growth of the Company… (Read more in Official Release)
For further information, please contact:
Mr Jason D’Arcy
Company Secretary
Telephone AUS: +614 1767 7732
Telephone US: +1 214 930 2233
Email: jason.darcy@azurehealthcare.com.au
